UBS Group AG - COCRYSTAL PHARMA INC ownership

COCRYSTAL PHARMA INC's ticker is and the CUSIP is 19188J409. A total of 17 filers reported holding COCRYSTAL PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of COCRYSTAL PHARMA INC
ValueSharesWeighting
Q2 2023$660
-83.4%
276
-86.1%
0.00%
Q1 2023$3,964
-59.5%
1,992
-60.3%
0.00%
Q4 2022$9,7795,0150.00%
Other shareholders
COCRYSTAL PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 3,348$6,2610.00%
JPMORGAN CHASE & CO 1,744$3,2610.00%
Renaissance Technologies 126,228$2360.00%
ROYAL BANK OF CANADA 9$00.00%
VANGUARD GROUP INC 275,656$515,4770.00%
FMR LLC 187$3500.00%
BANK OF AMERICA CORP /DE/ 9,028$16,8820.00%
WELLS FARGO & COMPANY/MN 89$1660.00%
NORTHERN TRUST CORP 12,207$22,8280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of COCRYSTAL PHARMA INC shareholders